Keith Y. Terada

1.8k total citations · 1 hit paper
50 papers, 1.3k citations indexed

About

Keith Y. Terada is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Epidemiology. According to data from OpenAlex, Keith Y. Terada has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Obstetrics and Gynecology, 23 papers in Reproductive Medicine and 15 papers in Epidemiology. Recurrent topics in Keith Y. Terada's work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Cervical Cancer and HPV Research (6 papers). Keith Y. Terada is often cited by papers focused on Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (22 papers) and Cervical Cancer and HPV Research (6 papers). Keith Y. Terada collaborates with scholars based in United States and South Korea. Keith Y. Terada's co-authors include David Shimizu, Marc T. Goodman, Katharine McDuffie, Lynne R. Wilkens, Pamela J. Thompson, Jan H. Wong, Jan H. Wong, Galina Lurie, Michael E. Carney and Hyeong Jun Ahn and has published in prestigious journals such as Journal of Clinical Oncology, Obstetrics and Gynecology and Epidemiology.

In The Last Decade

Keith Y. Terada

49 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer

2019 209 citations Marcus E. Randall, Virginia L. Filiaci et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith Y. Terada United States	19	533	530	293	243	232	50	1.3k
Shoji Haruta Japan	19	510 1.0×	814 1.5×	85 0.3×	114 0.5×	133 0.6×	60	1.3k
Kyu Ri Hwang South Korea	19	98 0.2×	643 1.2×	96 0.3×	109 0.4×	58 0.3×	57	1.1k
Nils Bolstad Norway	19	81 0.2×	98 0.2×	155 0.5×	153 0.6×	130 0.6×	87	1.1k
Emanuele Naglieri Italy	15	53 0.1×	196 0.4×	95 0.3×	336 1.4×	245 1.1×	42	1.0k
R.J. Pegoraro South Africa	22	192 0.4×	43 0.1×	218 0.7×	482 2.0×	598 2.6×	52	1.4k
Zerrin Calay Türkiye	15	396 0.7×	112 0.2×	67 0.2×	67 0.3×	125 0.5×	38	746
Guoyang Luo United States	19	152 0.3×	29 0.1×	214 0.7×	211 0.9×	144 0.6×	47	889
Amer Khiyami United States	20	32 0.1×	84 0.2×	955 3.3×	91 0.4×	469 2.0×	41	1.7k
Jong Jin Oh South Korea	21	49 0.1×	42 0.1×	161 0.5×	206 0.8×	455 2.0×	146	1.6k
Hermenegildo de la Calle Spain	21	24 0.0×	91 0.2×	151 0.5×	80 0.3×	463 2.0×	37	1.4k

Countries citing papers authored by Keith Y. Terada

Since Specialization

Citations

This map shows the geographic impact of Keith Y. Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Y. Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Y. Terada more than expected).

Fields of papers citing papers by Keith Y. Terada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Y. Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Y. Terada. The network helps show where Keith Y. Terada may publish in the future.

Co-authorship network of co-authors of Keith Y. Terada

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Y. Terada. A scholar is included among the top collaborators of Keith Y. Terada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Y. Terada. Keith Y. Terada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ahn, Hyeong Jun, et al.. (2020). Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8. Gynecologic Oncology Reports. 33. 100614–100614. 2 indexed citations

Randall, Marcus E., Virginia L. Filiaci, D. Scott McMeekin, et al.. (2019). Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancer. Journal of Clinical Oncology. 37(21). 1810–1818. 209 indexed citations breakdown →

Wong, Jennifer, et al.. (2018). Using gene expression in patients with endometrial intraepithelial neoplasia to assess the risk of cancer. Gynecologic Oncology Reports. 24. 24–26. 5 indexed citations

Terada, Keith Y., et al.. (2017). Ovarian needle aspiration in the diagnosis and management of ovarian masses. Journal of Gynecologic Oncology. 28(4). e40–e40. 15 indexed citations

Clinton, Lani, et al.. (2017). Low-Volume Lymph Node Metastases in Endometrial Carcinoma. International Journal of Gynecological Cancer. 27(6). 1165–1170. 15 indexed citations

Terada, Keith Y., Michael E. Carney, Robert Kim, Hyeong Jun Ahn, & Jill Miyamura. (2016). Health Disparities in Native Hawaiians and Other Pacific Islanders Following Hysterectomy for Endometrial Cancer.. PubMed. 75(5). 137–9. 2 indexed citations

Ahn, Hyeong Jun, et al.. (2016). Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions. International Journal of Gynecological Cancer. 26(2). 228–232. 15 indexed citations

Terada, Keith Y., et al.. (2013). Survival of endometrial cancer patients with lymphatic invasion and deficient mismatch repair expression. Gynecologic Oncology. 129(1). 188–192. 7 indexed citations

Lurie, Galina, Lynne R. Wilkens, Pamela J. Thompson, et al.. (2008). Combined Oral Contraceptive Use and Epithelial Ovarian Cancer Risk. Epidemiology. 19(2). 237–243. 37 indexed citations

10.

Hakim, Amy & Keith Y. Terada. (2006). Sentinel node dissection in vulvar cancer. Current Treatment Options in Oncology. 7(2). 85–91. 15 indexed citations

11.

Terada, Keith Y., David Shimizu, Caroline S. Jiang, & Jan H. Wong. (2006). Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecologic Oncology. 102(2). 200–203. 41 indexed citations

12.

Terada, Keith Y., et al.. (2004). DNA aneuploidy is associated with increased mortality for stage I endometrial cancer. Gynecologic Oncology. 95(3). 483–487. 14 indexed citations

13.

Ferrell, Robert E., Katharine McDuffie, Keith Y. Terada, et al.. (2004). Polymorphisms of interleukin (IL)-1α, IL-1β, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecologic Oncology. 95(3). 672–679. 66 indexed citations

14.

Goodman, Marc T., Katharine McDuffie, Chuanfa Guo, Keith Y. Terada, & Timothy A. Donlon. (2001). CYP17 genotype and ovarian cancer: a null case-control study.. PubMed. 10(5). 563–4. 13 indexed citations

15.

Muggia, Franco M., Pengfei Liu, David S. Alberts, et al.. (1996). Intraperitoneal Mitoxantrone or Floxuridine: Effects on Time-to-Failure and Survival in Patients with Minimal Residual Ovarian Cancer after Second-Look Laparotomy—A Randomized Phase II Study by the Southwest Oncology Group. Gynecologic Oncology. 61(3). 395–402. 29 indexed citations

16.

Reid, Gary C., Keith Y. Terada, James A. Roberts, et al.. (1992). Continuous infusion of low-dose 5-fluorouracil and radiation therapy for poor-prognosis squamous cell carcinoma of the uterine cervix. Gynecologic Oncology. 44(3). 227–230. 5 indexed citations

17.

Terada, Keith Y., et al.. (1991). The effect of megestrol acetate on interleukin-1 activity. Gynecologic Oncology. 43(3). 260–261. 3 indexed citations

18.

Terada, Keith Y., et al.. (1990). Potential clinical applications of c‐reactive protein. Journal of Clinical Laboratory Analysis. 4(3). 231–235. 72 indexed citations

19.

Terada, Keith Y., et al.. (1990). C-reactive protein and 6-keto prostaglandin F 1-α in patients with gynecologic cancer. Gynecologic Oncology. 36(2). 212–214. 2 indexed citations

20.

Terada, Keith Y., George W. Morley, & James A. Roberts. (1988). Stage IB carcinoma of the cervix with lymph node metastases. Gynecologic Oncology. 31(3). 389–395. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact